Publisher
Springer Science and Business Media LLC
Reference135 articles.
1. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell. 1992 Feb 21;68(4):799–808. https://doi.org/10.1016/0092-8674(92)90154-5.
2. Aslanidis C, Jansen G, Amemiya C, Shutler G, Mahadevan M, Tsilfidis C, et al. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature. 1992;355(6360):548–51. https://doi.org/10.1038/355548a0.
3. Bird TD. Myotonic Dystrophy Type 1. 1999 Sep 17 [updated 2021 Mar 25]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. PMID: 20301344.
4. Liao Q, Zhang Y, He J, Huang K. Global prevalence of myotonic dystrophy: an updated systematic review and meta-analysis. Neuroepidemiology. 2022;56:163–73. https://doi.org/10.1159/000524734.
5. Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 2012;11(10):891–905.